NTPDase1 activity attenuates microglial phagocytosis

Area of Science:

• Neuroimmunology
• Cellular Biology
• Biochemistry

Background:

• Purinergic signaling, involving P1 and P2 receptors, is critical for microglial phagocytosis.
• Extracellular enzymes modulate purinergic signaling by generating adenosine.
• Microglia express ecto-nucleoside triphosphate diphosphohydrolase 1 (CD39), an enzyme involved in purine metabolism.

Purpose of the Study:

• To investigate the role of CD39 in regulating microglial phagocytosis.
• To determine the impact of CD39 deletion on ATP and ADP degradation in the brain.
• To elucidate the interplay between CD39, purinergic receptors, and microglial phagocytic activity.

Main Methods:

• Comparison of ATP and ADP degradation in cultured microglia and astrocytes.
• Analysis of microglial phagocytic activity in wild-type and CD39-deficient (cd39(-/-)) mice using acute brain slices.
• Pharmacological manipulation of P1 and P2 receptors.

Main Results:

• CD39 expression significantly enhances ATP and ADP degradation in microglia compared to astrocytes.
• CD39 deletion in brain slices reduced ADP and ATP degradation by 50% and 75%, respectively.
• Microglia from cd39(-/-) mice exhibited increased constitutive phagocytosis, unresponsive to ATP stimulation.
• P2 receptor blockade reduced phagocytosis in both wild-type and cd39(-/-) microglia.
• P1 receptor activation decreased microglial phagocytic activity.

Conclusions:

• CD39 plays a key role in controlling extracellular ATP levels, thereby regulating microglial phagocytosis.
• The absence of CD39 leads to heightened microglial phagocytic capacity.
• Targeting CD39 may offer therapeutic strategies for modulating neuroinflammation.